Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Genzyme, a Sanofi Company · 2004
ClinicalTrials.gov · Datasets · License: Public Domain · 2004
Open Source ↗
na
acute myelogenous leukemia (aml), acute lymphocytic leukemia (all), graft vs. host disease (gvhd), anti-t cell antibodies, allogenic stem cell transplant, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831445
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.